Buscar resultados de ensayos clínicos
Camurati-Engelmann Disease - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Angiotensin II Antagonism of TGF-Beta 1 Condición:
Fecha: 2006-04-28 Intervenciones: Drug: Candesartan |
Active, not recruiting |
Nombre del estudio: TGF-beta Resistant Cytotoxic T-lymphocytes in Treatment of EBV-positive Nasopharyngeal Carcinoma / RESIST-NPC Condición: EBV-positive Nasopharyngeal Carcinoma Fecha: 2014-02-14 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Her2 and TGFBeta CTLs in Treatment of Her2 Positive Malignancy Condición: HER2 Positive Malignancies Fecha: 2009-04-24 Intervenciones: Biological: TGFBeta resistant HER2/EBV-CTLs Each patient w |
Completed |
Nombre del estudio: Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers Condición: Healthy Fecha: 2008-04-07 Intervenciones:
|
Withdrawn |
Nombre del estudio: Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome Condición: Marfan Syndrome Fecha: 2011-05-25 Intervenciones: Other: Blood draw This study includes one blood draw to measure circulating blood levels of TGF-B. |
Completed |
Nombre del estudio: Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects Condición: Hypertension Fecha: 2014-11-28 |
Completed |
Nombre del estudio: Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2 Condición:
Intervenciones: Drug: AP 12009 Initial scheme: AP 12009 (trabedersen), dos |
Recruiting |
Nombre del estudio: Study of Lymphodepletion Plus Adoptive Cell Transfer With TGF-beta Resistant (DNRII) and NGFR Transduced T-Cells Followed by High Dose Interleukin-2 in Participants With Metastatic Melanoma Condición: Melanoma Fecha: 2013-09-27 Intervenciones:
|
Completed |
Nombre del estudio: Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic Sclerosis Condición:
Fecha: 2002-08-12 Intervenciones: Drug: Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody |
Completed |
Nombre del estudio: Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D Condición: SLE Fecha: 2017-05-13 Intervenciones:
|